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ABSTRACT
Previously, we showed that cortical mineralization is coordinately adjusted to mechanically offset external bone size differences
between A/J (narrow) and C57BL/6J (wide) mouse femora to achieve whole bone strength equivalence at adulthood. The identity of
the genes and their interactions that are responsible for establishing this homeostatic state (ie, canalization) remain unknown. We
hypothesize that these inbred strains, whose interindividual differences in bone structure and material properties mimic that
observed among humans, achieve functional homeostasis by differentially adjusting key molecular pathways regulating external
bone size and mineralization throughout growth. The cortices of A/J and C57BL/6J male mouse femora were phenotyped and gene
expression levels were assessed across growth (ie, ages 2, 4, 6, 8, 12, 16weeks). A difference in total cross-sectional area (p< 0.01) and
cortical tissue mineral density were apparent between mouse strains by age 2 weeks and maintained at adulthood (p< 0.01). These
phenotypic dissimilarities corresponded to gene expression level differences among key regulatory pathways throughout growth.
A/J mice had a 1.55- to 7.65-fold greater expression among genes inhibitory toWnt pathway induction, whereas genes involved in
cortical mineralization were largely upregulated 1.50- to 3.77-fold to compensate for their narrow diaphysis. Additionally, both
mouse strains showed an upregulation among Wnt pathway antagonists corresponding to the onset of adult ambulation
(ie, increased physiological loads). This contrasts with other studies showing an increase inWnt pathway activation after functionally
isolated, experimental in vivo loading regimens. A/J and C57BL/6J long bones provide amodel to develop a systems-based approach
to identify individual genes and the gene-gene interactions that contribute to trait differences between the strains while being
involved in the process by which these traits are coordinately adjusted to establish similar levels of mechanical function, thus
providing insight into the process of canalization. © 2017 American Society for Bone and Mineral Research.
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Introduction
A major unresolved challenge for identifying genetic andenvironmental factors that contribute to skeletal health is
understanding how genes work together to establish system-
level function through canalization. Canalization in this context is
where a population demonstrates a similar phenotype, here a
mechanically competent bone, despite inherent environmental
and genotype differences. This process is achieved through
developmental adaptations that occur despite variation among
traits thatmay have arisen via differing biological or environmen-
tal conditions.(1) For bone, primary system-level function includes
establishing sufficient whole bone stiffness and strength during
growth to resist fracturing while minimizing mass for metabolic
conservation.(2,3) Targeted perturbation studies, such as gene
function alterations, have provided tremendous insight into the
identity of genes and molecular pathways that are involved in
establishingmechanical homeostasis.(4–8) However, these studies
are composed of selective decreases or increases in expression of
single genes,whichoften lead to abnormal function,(9–12) if not an
overt pathological state.(13,14) Therefore, it is difficult to determine
the coordination ofmultiple genes in a normal physiological state
from those that materialize when gene function is compromised.
Likewise, genome-wide association studies have successfully
located many quantitative trait loci (QTL) associated with select
bone traits but have not defined how these genetic variants
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cooperate to establish whole bone mechanical function at the
system level.(1,15) Thus, the ways in which genes interact to
establish normal, non-pathological mechanical function is not
well understood.
Our previous work has shown that in mice(16,17) and
humans(18–20) phenotypic traits interact in a coordinated
manner to establish a mechanically competent bone. For a
given external bone size, a subset of morphological and
compositional traits will predictably and coordinately adjust
to offset the overall size of the bone in the interest of
establishing and maintaining normal whole bone function.
For example, our mouse model is composed of two inbred
mouse strains that have employed different biological pathways
to achieve similar whole bone strength at skeletal maturity.(21,22)
A/J mice have a narrow (slender) femoral diaphysis compared
with the wide (robust) femoral diaphysis of C57BL/6J (B6) mice
(Fig. 1). Both strains have a similar body mass and bone length.
Therefore, to offset their differences in external bone size and
thus differing moment areas, they spatially distribute their
cortical tissue in different ways, with A/J having a thicker cortex
(ie, greater cortical area with respect to external diaphyseal
diameter) compared with the thinner cortex of their B6
counterpart. Moreover, A/J mice have a more mineralized
cortical matrix than B6 mice, which effectively increases the
whole bone stiffness of A/J femora to functionally match the
wide, more ductile femora of B6. Therefore, both mouse strains
have adapted their bone structure and tissue-level material
properties in different ways to maximize their skeletal stiffness
and strength while simultaneously minimizing their bone mass.
This phenomenon is consistent with the functional objectives
observed across many species,(2,23–25) including humans.(20,26)
This consistency in coordination among phenotypic traits is
established early in postnatal development inmice (2weeks of
age)(21) and humans (2 years of age)(27) and is maintained
throughout growth and into adulthood, leading us to
hypothesize that this trait adjustment mechanism is canalized
across species.(28) How this coordination among intermediate
physical bone traits is accomplished at the genetic level remains
unknown. Understanding this developmental mechanism may
be clinically important for characterizing how human bone
traits, which naturally vary among individuals, contribute to
aging and respond to pharmacological interventions aimed at
reducing fracture risk.
Here, we use the A/J and B6 mouse model described above to
begin investigating the molecular pathways between these two
mouse strains whose interindividual differences in bone
structure and material properties mimic that observed among
humans.(29) This is a departure from a traditional targeted
genetic approach, as we seek to investigate system-wide
differences among unperturbed mice to investigate how genes
interact to establish normal level function. This model can be
used to determine how the system compensates for allelic and
environmental factors that might disrupt homoeostasis, partic-
ularly those that influence the marked differences in external
bone size, cortical thickness, and tissue mineralization between
the two mouse strains.
We hypothesize that both mouse strains achieve a similar
whole bone mechanical homeostatic state through the
differential regulation of key molecular pathways contributing
to the phenotypic morphological and compositional traits that
differentially arise during growth. We tested this hypothesis by
conducting three aims: 1) to identify which bone genes are
differentially expressed between strains at multiple time points
during postnatal growth, 2) to ascertain which bone-relevant
pathways are differentially regulated throughout postnatal
growth between strains, and 3) to determine how these gene
expression profile differences between strains relate to their
respective bone phenotypes at multiple time points across
skeletal growth. Our goal is to understand how whole bone
function is achieved at the molecular level through the
differential coordination of traits, while illuminating the manner
in which this mechanism may be canalized.
Materials and Methods
Before the study outlined herein, a pilot study was conducted
using both male and female B6 and A/J mice at multiple time
points. No statistical sex-specific difference was noted within the
phenotypic or gene expression results, therefore the following
study only focuses onmales. Male B6 and A/J mice were acquired
from The Jackson Laboratory (Bar Harbor, ME, USA) at multiple
ages that span postnatal skeletal growth. Upon arrival, mice were
allowed to acclimate for 1 week before euthanization. All mice
were provided water and fed a standard rodent diet (Purina
Rodent Chow 5001; Purina Mills, Richmond, IN, USA) ad libitum.
Micewere housed at amaximumof 5mice per cage and exposed
to a 12-hour light/dark cycle. Left and right femora for phenotypic
and genotypic analyses were harvested from 2-, 4-, 6-, 8-, 12-, and
16-week-old mice. These ages were chosen because it is during
early postnatal growth when traits are coordinately adjusted to
establish whole bone mechanical function at adulthood.(21) The
University of Michigan Institutional Animal Care and Use
Committee approved all mouse studies.
Phenotypic analysis
Changes in femoral diaphyseal growth were assessed at six time
points throughout development (ie, 2, 4, 6, 8, 12, and 16 weeks).
Fig. 1. Schematic highlighting the key morphological and composi-
tional differences between male A/J and B6 mice at age 16 weeks. Note
that at this age of skeletal maturity these mouse strains demonstrate
equivalent bone strength. Images taken using nanoCT at an 8-mm voxel
size.
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Left femora were harvested from male A/J and B6 mice (n¼ 10/
age/strain). Bodymass (BM)wasmeasured before euthanization.
Maximum femur length (Le) was measured from the most
proximal tip of the greater trochanter to the distal condyles
using digital calipers (0.05mm resolution). All femora were
imaged at an 8-mm voxel size using a nanotom s (phoenix|x-ray,
GE Sensing and Inspection Technologies, GmbH, Wunstorf,
Germany), converted to Hounsfield units using a phantom of
air, water, and hydroxyapatite (1.69mg/cc; Gammex, Middleton,
WI, USA) and reconstructed using datos|x reconstruction
software (phoenix|x-ray, GE Sensing and Inspection Technolo-
gies, GmbH) as described previously.(22) Imaging parameters
were varied slightly per age group to accommodate the
different attenuations of the bone across groups (80 to 90 kV,
220 to 375 mA, 750 to 2000ms, 3 to 4 average, 1 skip, 0.3mm Al
filter). These parameters were validated in house to provide the
best visualization of characteristics at specific ages. From each
image file, the region of interest (ROI) analyzed consisted of a
15% to 19% region of the mid-diaphysis taken just distal to the
third trochanter. Each ROI was thresholded using Otsu’s
method.(30) ROIs were defined and variables were quantified
using MicroView v2.2 Advanced Bone Analysis Application
software (GE Healthcare Pre-Clinical Imaging, London, ON,
Canada). Variables quantified included total cross-sectional area
(Tt.Ar), cortical area (Ct.Ar), marrow area (Ma.Ar), and tissue
mineral density. Cortical tissue mineral density (Ct.TMD) was
derived from the mean gray value using calibration phantoms.
After computed tomography, left femora from mice aged
4 weeks and older were loaded to failure using a custom 4-point
bending fixture at a displacement rate of 0.05mm/sec (MTS 858
MiniBionix; Eden Prairie, MN, USA). Bones were kept moist with
1 phosphate-buffered saline (PBS) and tested at room
temperature (RT) with the anterior surface of the femur in
tension. Variables calculated from the load-deflection curves
included stiffness (S), maximum load (ML), post-yield deflection
(PYD), andwork-to-fracture (Work), as described previously.(31,32)
Two-week-old femora were not tested because of the insuffi-
cient lamellae at this growth stage to adequately perform four-
point bending tests.
Gene expression analysis
Tissue preparation and RNA extraction
Gene expression profiles were obtained from RNA extracted
from the femoral diaphysis of 2-, 4-, 6-, 8-, 10-, and 12-week-old
male A/J and B6 mice. Sixteen-week-old mice were not used for
gene expression assays because RNA concentrations yielded
were drastically different between strains and, in total,
substantially lower than those of the other six time points. For
qPCR, 18 mice per strain and age were analyzed (6 pools of 3
mice/strain/age). For RNA sequencing, 8 mice per strain were
analyzed at age 6 weeks. Mice were anesthetized with isoflurane
(Piramal Healthcare, Ltd., Andhra Pradesh, India) and euthanized
via cervical dislocation and a bilateral pneumothorax. For RNA
extraction, the left and right femur of each animal was harvested
and any adhering periosteum, muscle, tendon, and ligament
were removed to detach adhering cells along the periosteal and
endosteal surfaces. Next, the proximal and distal epiphyses were
excised and the bone marrow was manually flushed using
minimum essential medium, alpha (Gibco, ThermoFisher
Scientific, Waltham, MA, USA). A histological analysis on a
subset of processed bones confirmed that our tissue-harvesting
protocol was effective at removing most of the adhering cells
along the periosteal and endosteal surfaces (data not shown).
Complete tissue preparation for each sample occurred within
6 minutes after death. Bone samples were then immediately
flash frozen in liquid nitrogen and stored at –80°C.
RNA extraction was achieved by pulverizing the pair of bones
in 2mL of TRIzol (Life Technologies, Grand Island, NY, USA) using
a high-speed tissue homogenizer (Model 1000; ThermoFisher
Scientific). Each sample was subjected to three cycles of
20-second homogenization, placing the sample on ice between
cycles to reduce thermal accumulation and subsequent RNA
degradation. Total nucleic acid content was then isolated from
the bone mineral and protein using 0.2mL of 24:1 chloroform:
isoamyl alcohol per 1mL of TRIzol and subsequently centrifuged
at 12,000g for 15minutes at 4°C. The supernatant containing the
RNA fraction was then further purified using the RNeasy Mini Kit
(Qiagen, Valencia, CA, USA) and the DNA was digested on
column using an RNase-Free DNase Set (Qiagen), according to
the manufacturer. Total RNA was then recovered in 30mL of
RNase-free water. RNA concentration for each sample was
determined using NanoDrop 2000 (ThermoFisher Scientific).
RNA quality was assessed using a bioanalyzer (Model 2100;
Agilent Technologies, Santa Clara, CA, USA). All samples with a
260/280 nm absorbance ratio of 1.8 or greater and an RNA
integrity number greater than 8.0 were deemed to be of
sufficient purity and quality for use in downstream analyses.
RNA-sequencing methodology
Whole transcriptome RNA sequencing was conducted individu-
ally on the messenger RNA (mRNA) of 8 pairs of femora from
male A/J mice and 8 pairs of femora from male B6 mice at age
6 weeks. This time point was chosen because this is the age
when the external size of the B6 and A/J femoral diaphysis
begins its greatest divergence from one another (as reported in
Results). Before library construction, each RNA sample was
depleted of its ribosomal RNA (RiboGone; Clontech, Mountain
View, CA, USA), according to the manufacturer. An mRNA library
for each sample was subsequently prepared using the SMARTer
Stranded RNA-Seq Kit (Clontech). All buffer volumes, times, and
temperature settings used to construct the library were exactly
as recommended in the manufacturer’s protocol. Briefly, mRNA
was fragmented to obtain segments of200 base pairs in length
and converted to single-stranded cDNA that was ligated to
barcode adapters. cDNA fragments were then purified using
Agencourt AMPure XP magnetic beads (Beckman Coulter, Brea,
CA, USA). After purification, cDNA was amplified into
RNA-sequencing libraries using DNA polymerase, a universal
forward PCR primer, and reverse PCR primers corresponding to
the paired-end Illumina primer index. Once amplified, the
RNA-sequencing library was purified using Agencourt AMPure
XP magnetic beads and validated with a bioanalyzer. Upon
library completion, equal volumes of stranded, bar-coded cDNA
libraries generated from the left and right femora of eachmouse
(A/J, n¼ 8; B6, n¼ 8) were multiplexed and sequenced in
quadruplicate (4 lanes of flow cell) using a HiSeq 2500 System
(Illumina, San Diego, CA, USA) to obtain a minimum of 25million
base-pair reads per library.
Upon completion of sequencing, the quality of the raw reads
data for each sample was checked using FastQC v1.10.1 (www.
bioinformatics.bbsrc.ac.uk/projects/fastqc). Next, raw reads
were aligned to the appropriate reference genomes for the
A/J and B6 mouse strains using TopHat v2.0.9 and Bowtie v2.1.0.
The reference genomes and the corresponding GTF files for the
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A/J and B6 strains were downloaded from the Center of Genome
Dynamics at The Jackson Laboratory (http://cgd.jax.org/tools/
Seqnature.shtml). Alignment quality was checked using FastQC
to ensure only high-quality data were used for expression
quantification and differential gene expression analysis. Expres-
sion quantification at the gene level was performed using the
htseq-count script embedded in HTseq. (33) This python script
uses the BAM (TopHat/Bowtie output) and GTF files for
generating the counts of aligned reads for each gene that
overlapped its exons. The htseq-count script is designed to only
count reads that mapped unambiguously to a single gene, thus
reads aligned to multiple positions or overlapping with more
than one gene were discarded. The counts were then used for
gene-level differential expression analyses using edgeR.(34) To
correct for the false discovery rate (FDR, q) p values were
adjusted for multiple hypotheses testing using a Benjamini-
Hochberg procedure (q¼ 0.05). Genes and transcripts that were
differentially expressed between A/J and B6 mice had to not
only have a q value less than or equal to 0.05 but also a fold
change (D) (up or down) greater than or equal to 1.5. Pathway
enrichment analysis was initially performed using Gene
Ontology.(35) Ingenuity Pathway Analysis software (Qiagen)
was then used to identify significantly differentially expressed
canonical pathways and functional groupings of genes. Pathway
analyses were performed using a right-tailed Fisher’s exact test
to generate a p value representing the probability that
differentially expressed genes placed in a given pathway were
not due to random chance and a Benjamini-Hochberg
correction was applied to account for multiple comparisons
(q¼ 0.05).
RNA sequencing was confirmed and validated using a custom
TaqManmicrofluidic array card (Applied Biosystems, Foster City,
CA, USA) that encoded for 45 Wnt pathway-related genes and
three endogenous controls using qPCR (Model 7900HT RT-PCR;
Applied Biosystems) (Supplemental Table S1). As reported in the
results below, an enrichment analysis using Gene Ontology of
the RNA-sequencing data showed the canonicalWnt pathway to
be significantly differentially expressed (2-fold) between the
A/J and B6 mouse femora.
qPCR analysis
Gene expression changes in both B6 and A/J mouse strains
across growth were tracked using cDNA generated from
2-, 4-, 6-, 8-, 10-, and 12-week-old male mice. RNA samples
were combined into 6 pools per strain and age (3 samples per
pool) to yield 200 ng of RNA per pool. Reverse transcription was
performed on each pooled sample using qScript cDNA SuperMix
(Quanta Biosciences, Gaithersburg, MD, USA) and was run in a
C1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA)
according to the manufacturer. Each cDNA sample was then
combined with TaqMan Gene Expression Master Mix (Applied
Biosystems) and loaded into custom 384-well microfluidic array
cards containing 45 unique primers related to the canonical and
non-canonical Wnt pathways and three endogenous control
primers (Supplemental Table S1). Each card allowed for 8-pooled
samples to be run simultaneously. Cards were then centrifuged
at 4°C (Legend XTR with custom TaqMan array card bucket;
Sorvall, Waltham, MA, USA) and sealed. Cards were run in
accordance with the manufacturer’s recommendations.
After the generation of the amplification plots, the baseline
and threshold settings were adjusted to obtain an accurate
threshold cycle (CT) that was the same for both strains at each
given age. A comparative CT method (DDCT) was used to
calculate fold-change expression levels by normalizing the data
to an endogenous reference.(36) Because of the specificity,
sensitivity, and amplification efficiency of the TaqMan assays,(37)
fold changes (up or down) of 1.5 or greater that were identified
as being statistically significant (p< 0.05) via a paired t test met
our criteria for denoting differences in gene expression levels
between the two strains.
Protein analysis
Left and right femora of B6 and A/J 6-week-old male mice
(n¼ 10/strain) were harvested in the same manner as
described for RNA preparation. Whole cell extracts (lysates)
were obtained by homogenizing both femora of two mice
(5 pools/strain) in 50mM Tris-base, 150mM sodium chloride,
2mM ethylene glycol tetraacetic acid, 10mM sodium
pyrophosphate decahydrate, and 10% nonyl phenoxypolye-
thoxylethanol for 30 seconds. Equal protein lysate concen-
trations (13mg per pool) were separated on 4% stacking gels
and 12% SDS-PAGE gels (150V, 90minutes) and transferred to
nitrocellulose membranes (100V, 60minutes). Membranes
were blocked for 1 hour at RT with 5% bovine serum albumin
(BSA) diluted in Tris-buffered saline containing 0.05% Tween
20 (TBS-T). After blocking, the membranes were incubated
overnight at 4°C with a rabbit polyclonal anti-sclerostin
antibody (sc130258, Santa Cruz Biotechnology, Dallas, TX,
USA) diluted at 1:200 in 5% BSA. Membranes were then
washed in TBS-T and incubated in a goat anti-rabbit
immunoglobulin-G horseradish peroxidase-conjugated sec-
ondary antibody (sc2004, Santa Cruz Biotechnology) diluted at
1:20,000 in 5% BSA for 1 hour at RT. After rinsing in TBS-T, the
blots were developed on Fuji HR-T X-ray film (Fujifilm Medical
Systems, Stamford, CT, USA) using SuperSignal West Femto
Maximum Sensitivity Substrate (ThermoFisher Scientific).
Statistical analysis
All data were analyzed using Minitab v16 (State College, PA,
USA) and Prism v6 (GraphPad Software, La Jolla, CA, USA). A
Shapiro-Wilk test confirmed that the data were normally
distributed. To test for phenotypic differences between strains
at each age, a general linear model (GLM) analysis of variance
(ANOVA) was employed. A GLM was used to adjust all traits
relative to BM for each age separately, which is a known
covariate to these traits. Additionally, Tt.Ar was included as a
covariate to Ct.Ar, Ma.Ar, and Ct.TMD because these traits vary
relative to external bone size. Significance was taken at a p value
equal to or less than 0.05. An analysis of covariance (ANCOVA)
was employed to test for significance in growth trajectories
betweenmouse strains for Tt.Ar and Ct.TMD because these traits
have previously been shown to have the greatest divergence
between strains. This was done by plotting each trait against the
logarithm of age to linearize the data, followed by a comparison
of the slopes and y-intercepts to determine differences in
phenotypes across growth. Using a Bonferroni correction to
adjust for multiple comparisons, significance of the phenotypic
data between strains across ages was based on an alpha level of
0.008. Effect sizes were reported as Cohen’s d. These were
calculated as the difference between themeans between strains
for any given trait divided by the pooled standard deviation of
those means. Gene expression level differences between mice
strains were quantitatively assessed as described in the Gene
Expression Analysis subsection of Materials and Methods.
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Western blot data was analyzed using a paired t test with
significance taken at a p value equal to or less than 0.05.
Results
Femoral phenotypes for both B6 and A/J mice were
largely established by age 2 weeks
The unadjusted and adjusted means along with the standard
deviations of all pertinent phenotype data are listed in
Supplemental Table S2. By age 2 weeks, a significant 33%
difference in external bone size (ie, Tt.Ar) between A/J and B6
micewas established andmaintained throughout growth to age
16 weeks (A/J: 0.68–1.33mm2; B6: 1.01–2.04mm2; effect
size¼ 4.39–6.77; p< 0.001, GLM ANOVA; slope: p< 0.0001,
ANCOVA) (Fig. 2A). Periosteal expansion of the femoral diaphysis
was largely complete in both strains by age 8 weeks. Ma.Ar
increased between ages 2 and 4 weeks within both strains, with
A/Jmice showing significantly lessmarrow space into adulthood
compared with B6 (A/J: 0.57–0.97mm2; B6: 0.64–1.04mm2;
effect size¼ 1.23–3.71; p< 0.07–0.001, GLMANOVA) (Fig. 2C). Ct.
Ar relative to external diaphyseal size was significantly higher in
A/J femora compared with B6 femora across growth (ages 2 to
16 weeks), which explains their thicker cortex (A/J: 0.26–0.91
mm2; B6: 0.20–0.85mm2; effect size¼ 1.23–3.71;
p< 0.07–0.0001, GLMANOVA) (Fig. 2B). For A/J to accommodate
a narrower diaphysis while not drastically altering their absolute
volume of tissue, they significantly increased their Ct.TMD by
age 8 weeks (A/J: 1321 32.61mg/cc; B6: 1257 31.28mg/cc;
effect size¼ 2.00; p¼ 0.004, GLM ANOVA; y-intercept:
p< 0.0001, ANCOVA) (Fig. 2D). This tissue-level adjustment
partially contributed to a 10% significant difference in whole
bone stiffness (A/J: 215.4 23.9 N/mm; B6: 195.0 23.4 N/mm;
effect size¼ 0.86; p¼ 0.02, GLM ANOVA) (Fig. 3A) but only a 3%
non-significant difference in ML at age 16 weeks (A/J:
28.6 2.5 N; B6: 27.7 2.4 N; effect size¼ 0.35; p¼ 0.33, GLM
ANOVA) (Fig. 3B). However, these adjustments in cortical
mineralization, and in turn whole bone stiffness, in A/J femora
throughout growth came at a mechanical cost, resulting in a
more brittle bone as evidenced by the 62% to 77% significant
difference in post-yield displacement between strains through-
out growth (A/J: 0.12–0.24mm; B6: 0.33–0.90mm; effect
size¼ 2.13–7.28; p< 0.001, GLM ANOVA) (Fig. 3C). This lower
post-yield displacement largely contributed to the 41% to 58%
significantly less work-to-fracture in A/J during growth (AJ:
4.92–7.33Nmm; B6: 8.35–14.21Nmm; effect size¼ 1.48–4.62;
p< 0.005, GLM ANOVA) (Fig. 3D). This phenotypic analysis thus
confirms that the primary morphological and compositional
differences between B6 and A/J femora were external bone size
and tissue mineral density and that these differences are
apparent as early as age 2 weeks.
Femoral gene expression profiles significantly differed
between B6 and A/J mice
RNA sequencing of the femoral cortical matrices of 6-week-old
A/J and B6 mice yielded 4290 genes that showed significant
differential expression between strains (q 0.05, fold 1.5).
From these genes, we identified 9 canonical pathways that
largely encompass the morphological (ie, external bone size)
and compositional (ie, cortical matrix mineralization) develop-
ment of bone (Supplemental Table S3). The canonical (b-catenin)
and non-canonical (PCP, Caþ) Wnt pathways were integral to
many of the identified pathways and the majority of the
recognized genes encompassing these 9 pathways demon-
strated at least a 1.5-fold increased expression in A/J mice
relative to B6 mice. The enrichments of greatest interest,
selected using Gene Ontology, are listed in Table 1. These
enrichments were all upregulated in A/J mice relative to B6 and
qualitatively correlated well with the phenotypic differences
observed between these mice at skeletal maturity (ie, Tt.Ar and
Ct.TMD).
The canonical Wnt pathway, which is instrumental in driving
mesenchymal stem cells toward the osteoblastic lineage,
demonstrated a twofold enrichment between mouse strains.
Ingenuity Pathway Analysis identified 45 of 165 known Wnt
pathway-related genes in our bone samples. All but six of these
genes showed greater expression in A/J relative to B6. Using
knockout/knockdown models, others have identified several of
these 45 genes to be antagonistic to the canonicalWnt pathway.
Fig. 2. Mean and standard deviations of bonemorphological and compositional traits acrossmultiple time points during growth and development after
adjusting for body mass (A) or both body mass and total area (B–D). (A) Total area (Tt.Ar); (B) cortical (Ct.Ar); (C) marrow area (Ma.Ar); (D) cortical tissue
mineral density (Ct.TMD).  Denotes significant differences between B6 and A/J mice at the p< 0.05 alpha level.
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When looking at the total net accumulated perturbation
(a gene’s measured fold change combined with the accumu-
lated perturbation transmitted from any upstream genes) of
each of the 45 genes identified in our data set, the greater
antagonism of the canonical Wnt pathway in A/J through
disruption of Wnt ligand signaling and binding translated
downstream into a reduction in Dvl and b-catenin, as well as
reduced Tcf/Lef transcription. Fig. 4 demonstrates this outcome
on the Wnt/b-catenin KEGG pathway. These RNA sequencing
results were validated by our qPCR analysis of Wnt pathway-
related genes (below).
An additional outcome of the Gene Ontology and Ingenuity
Pathway analyses was the identification of several genes that
collectively play a substantial role in bone mineralization (log
(p)¼ 3.54e-03 and 1.86e-09, respectively). The expression levels
of the majority of these genes were elevated in A/J femora
relative to B6 femora. Of particular note was that A/J showed
greater expression among genes recently discovered to
comprise the acidic serine aspartate-rich Mepe-associated motif
(ASARM) bone-renal mineral pathway, which includes Phex (fold
D¼ 2.45), Dmp1 (fold D¼ 2.19), and Mepe (fold D¼ 2.86).
Complementing the greater expression of these genes in A/J
femora was the elevated gene expression levels of many other
genes known to play a functional role in bone mineralization
(Supplemental Table S4), relative to B6. The greater expression
level of these genes in A/J femora qualitatively correlates with
the higher Ct.TMD values observed in the phenotypic analysis of
these mice.
Expression levels of Wnt pathway antagonist genes were
higher in A/J femora, but expression levels shifted at a
greater magnitude in B6 mice throughout growth
Mapping the canonical and non-canonicalWnt pathway-related
gene expression profiles across growth using the custom
microfluidic array cards highlighted several differences between
A/J and B6 mice. Throughout growth, many of the 45 genes
assayed that are involved in either the induction or inhibition of
canonical Wnt pathway signaling demonstrated elevated
expression in A/J mice relative to B6 mice (Table 2). Genes
that were elevated in expression among A/J mice that suggest
pathway induction included Wnt10b, Ctnnb1, Lef1, and Tcf7,
whereas genes that suggest pathway inhibition because of their
elevated expression in A/J mice included Wif1, Sost, Dkk1, Dkk2,
Sfrp1, and Sfrp4. Despite this juxtaposition in higher expression
levels among genes that either promote or suppress canonical
Wnt pathway signaling within A/J mice relative to B6 mice, the
inhibitors collectively exhibited greater expression levels than
their downstream targets involved in an activated pathway
(Fig. 5). This suggested that A/J mice have some degree of
sustained Wnt pathway inhibition throughout growth with
respect to B6 mice, similar to the results obtained from the RNA
sequencing of 6-week-old mice. Sost showed the greatest
difference in expression levels among these inhibitory genes,
which was confirmed at the protein level (ie, sclerostin) in
6-week-oldmice via Western blots. A/J had a significantly higher
concentration (p¼ 0.03) of sclerostin compared with B6 (Fig. 6).
Fig. 3. Mean and standard deviations of mechanical four-point bending data across multiple time points during bone growth and development after
adjusting for body mass. (A) Stiffness; (B) maximum load; (C) post-yield displacement (PYD); (D) work-to-fracture (work). Denotes significant differences
between B6 and A/J mice at the p< 0.05 alpha level.
Table 1. Enrichment of Genes Playing Key Roles in Bone Development Identified Using Gene Ontology’s Panther Classification System
Functional enrichments No. of genes log (p value) Fold enrichment
Collagen fibril organization 21 5.70e-03 3.66
Regulation of osteoblast differentiation 46 1.33e-04 2.58
Regulation of bone mineralization 31 3.54e-03 2.85
Skeletal system morphogenesis 71 1.58e-04 2.08
Regulation of canonical Wnt signaling pathway 53 2.57e-02 2.00
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To determine the magnitude in which expression profiles of
genes involved in the Wnt pathway changed across growth
between A/J and B6 mice, the DDCT values for each gene
analyzed were plotted as a function of age by normalizing the
values at each time point to the DDCT values at age 2 weeks (ie,
their baseline expression level). Normalization of gene expres-
sion levels within both strains to their respective 2-week age
revealed that although A/J mice have greater overall gene
expression with regard to genes involved in the Wnt pathway
across growth relative to B6 mice, B6 mice actually showed
greater shifts in gene expression among genes compared with
A/J mice (Fig. 7). The gene demonstrating the greatest
expression level change at all time points across growth in
both mouse strains was Sost. From their baseline fold change
ratio of 1 at age 2 weeks, A/J showed a maximum 5-fold change
in expression during growth, whereas B6 showed a maximum
7.5-fold change in expression.
Discussion
We tested the hypothesis that A/J and B6 mice achieve a
mechanical homeostatic state through the differential regula-
tion of key molecular pathways that correspond with their
phenotypic differences in external femoral bone size and
mineralization. RNA sequencing and qPCR analyses were
conducted on cortical bone of the femoral diaphysis. Analyses
of femoral bone RNA throughout growth found significantly
different gene expression profiles present between A/J and B6
mice as early as age 2 weeks. This timeframe corresponded to an
age when a difference in Tt.Ar and Ct.TMDwas already apparent
between A/J and B6 male mouse femora, suggesting that the
differing biological pathways employed to achieve bone
mechanical competence is canalized. Many of the genes
identified from RNA sequencing reflect bone development,
with expression levels of these genes being largely greater for
A/J mice relative to B6 mice. Collectively, the genes identified
comprise pathways involved in bone homeostasis and minerali-
zation.(7) The canonical Wnt pathway, which many have shown
to drive osteoblastic differentiation and thus an increase in bone
formation (see Baron and Kneissel(7) for a review), was found to
play an integral role in many of the enriched pathways resulting
from the RNA sequencing of these 6-week-old mice. An
assessment of key genes encompassing this pathway across
multiple time points during growth found gene expression
levels that were primarily expressed at a higher level among A/J
males relative to B6 males. Because A/J mice show a narrower
femoral diaphysis, albeit with a relatively thicker, more
mineralized cortex, the elevated expression levels among
several genes known to either inhibit Wnt signaling or increase
cortical mineralization at age 6 weeks suggested a compensa-
tory mechanism may be in place to adjust tissue-level strength
relative to external bone size. This hypothesis is bolstered with
the finding of greater expression levels among genes
involved in the ASARM bone-renal pathway, which has been
shown to play a regulatory role in mineralization, phosphate
regulation, soft-tissue calcification, osteoclastogenesis, and
mechanotransduction.(38)
Also of interest from the phenotype and gene expression data
is that despite relatively greater gene expression levels among
Wnt pathway inhibitors in A/J mice, gene expression levels, after
being normalized to the 2-week time point (ie, baseline
expression level), tended to increase during growth at a greater
magnitude (ie, fold) among B6 mice compared with that of A/J
mice. Thus, there are strain and age-specific gene expression
differences. This shift in expression levels among Wnt pathway
inhibitory genesmay provide amechanismwhere the periosteal
expansion of B6 diaphyses, which are already wide relative to
A/J, is held in check, particularly during the rapid growth phase
occurring between ages 4 and 8 weeks. Additionally, the lower
expression levels of genes involved in cortical mineralization
among B6 mice at age 6 weeks complements the phenotypic
data concerning their lower Ct.TMD relative to their A/J
counterparts, who show increased signaling for mineralizing
activity to offset their narrow diaphysis.
Collectively, the gene expression profile data support the
dichotomy in external bone size and whole bone stiffness
observed phenotypically throughout growth between A/J and
B6 mice. By differentially inducing or inhibiting molecular
pathways known to play a role in bone homeostasis, it would
appear that A/J and B6 mice are able to maintain an intricate
Fig. 4. Schematic of the canonicalWnt pathway modeled after the KEGG diagram, highlighting the total perturbation of genes (a gene’s measured fold
change combinedwith the accumulated perturbation transmitted from any upstream genes) identified via RNA sequencing of B6 and A/Jmouse femora
at age 6 weeks. Color scale denotes the perturbation level of A/J femoral genes relative to those of B6. Blue denotes a decrease in a gene’s functional role
and red denotes an increase in a gene’s functional role.
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balance between bone mass and strength in the interest of
achieving a mechanically and metabolically functional bone at
adulthood. This outcome was not unexpected because Currey
and Alexander(2) hypothesized years ago that the ultimate goal
of bone is to achieve mechanical and metabolic function
through a balance of stiffness and mass. The phenotypic and
gene expression profiles of mice comprising our model support
this hypothesis, with A/J and B6 mice potentially reaching the
same functional endpoint through the differential regulation of
genes encompassing the Wnt pathway and functional
mineralization network involved in achieving a homeostatic
state between external bone size (ie, mass) and cortical
mineralization (ie, tissue stiffness).
Our assessment of gene expression within the Wnt pathway
during growth provided new insight into the role of Sost, and
other inhibitors of theWnt pathway (eg, Dkk1, Dkk2, Sfrp1, Sfrp4,
etc.), on the development of external bone size. Sost encodes the
protein sclerostin, a major antagonist to the Wnt pathway in
bone, which effectively blocks Wnt ligands from binding to the
Lrp5/6 receptors thereby inhibiting downstream signaling.(39,40)
Outcomes of targeted knockout studies(41–44) and studies
suppressing sclerostin expression using monoclonal antibod-
ies(45–48) have consistently shown that activation of the Wnt
pathway is associated with increased periosteal expansion and
marrow infilling. In our study, A/J mice demonstrated a narrow
femoral diaphysis with a 2- to 8-fold higher Sost expression
throughout growth relative to B6 femora. Although periosteal
expansion is largely completed by age 8 weeks in A/J femoral
diaphyses, they continue to deposit bone endosteally to offset
their narrow diaphysis. This continuation of marrow infilling
once periosteal expansion ceases is important as it enables A/J
mice to achieve a near similar Ct.Ar as B6 mice in the interest of
constructing amechanically competent bone that is comparable
to the whole bone strength and stiffness achieved by B6 upon
skeletal maturity. This outcome suggests that the diaphyseal
phenotype observed in A/J femora is not solely dependent on
Sost expression but most likely depends on interactions among
many genes. Moreover, the roles Sost and other Wnt pathway
inhibitors play throughout growth may differ depending on the
age of the mouse, as others have previously shown.(49) Overall,
the outcome of the gene expression analysis narrows the focus
of alleles and suggests that allelic differences between A/J and
B6 mice lead to suppression of the entire Wnt pathway in A/J
mice, while bolstering their functional competence with a
greater expression level among genes integral to an increase in
cortical mineralization. To further explore how mechanical
function is established during growth, it would be beneficial to
expand analyses to naturally perturbed mouse strains (eg,
recombinant inbred, chromosome substitution, collaborative
cross, heterogeneous stock). These strains are largely non-
pathologic and canminimize the interpretive complications that
may arise from the presence of flanking genes in targeted gene
perturbation models.(50)
Although a comparison of gene expression differences
between A/J and B6 was consistent with expectations for the
role of Wnt signaling in regulating external bone size, a
comparison of gene expression across growth was inconsistent
with previous studies. The 2- to 7.5-fold increase in Sost
expression between ages 2 and 4 weeks for A/J and B6 mice
was in juxtaposition to the findings of others who reported a
decrease in Sost expression among mice subjected to artificially
applied loads.(41–44,51) This was unexpected because it has been
reported that mice transition into full adult ambulatory activities
between these time points,(52) which presumably places greater
physiologically relevant, weight-bearingmechanical loads on the
skeletal system. The discrepancy between these outcomes could
result fromdifferences in the ages (eg, 10 to 20weeks of age) and
skeletal elements (eg, ulnae, tibias, fibulae) of the animals
investigated in prior studies,(41,42,44) or from the assumption that
tissue strains would increase during the initial phases of
ambulation. Moreover, differences between our findings and
those of others may indicate that genes and the proteins they
encode potentially play different roles depending on whether
Table 2. Gene Expression Differences of Wnt Pathway-Related











Gene Fold D Fold D Fold D Fold D Fold D
Wnt1 2.66 " 1.35 3.08 " 3.18 " 3.34 "
Wnt5a 1.78 " 0.93 2.06 " 2.65 " 3.32 "
Wnt6 0.47 # 0.52 0.54 0.77 2.70 "
Wnt7b 1.62 " 0.57 # 1.53 " 1.98 5.48 "
Wnt10a 1.31 0.82 1.34 2.06 " 5.36
Wnt10b 1.84 " 0.88 2.01 " 1.99 " 3.71 "
Fzd1 1.28 0.88 1.88 " 1.72 " 2.72 "
Fzd2 1.79 " 1.22 3.75 " 4.40 " 7.09 "
Fzd6 1.07 0.87 1.33 1.80 " 3.58 "
Fzd8 1.68 " 0.95 1.86 " 2.94 " 3.50 "
Lrp4 1.23 0.79 1.74 " 2.10 " 3.29 "
Lrp5 1.18 0.83 2.50 " 1.82 " 3.88
Lrp6 1.10 0.96 1.76 " 1.56 2.40 "
Dvl1 1.45 0.97 1.78 " 1.75 " 2.31 "
Axin1 1.25 0.87 1.25 1.26 1.60 "
Axin2 1.28 0.99 2.51 " 2.34 " 4.45 "
Apc 1.12 0.98 1.68 " 1.74 " 3.34 "
Gsk3b 1.07 0.92 1.45 1.49 2.64 "
Ctnnb1 1.28 0.85 1.84 " 1.90 " 3.04 "
Lef1 0.85 1.00 1.78 " 1.77 " 3.48 "
Tcf7 1.29 1.04 2.38 " 2.70 " 2.81 "
Sfrp1 0.97 1.19 1.44 2.02 " 2.05 "
Sfrp4 1.55 0.89 1.67 " 1.55 " 2.43 "
Wif1 0.73 0.74 1.98 " 2.67 " 3.77 "
Sost 7.65 " 1.70 " 5.91 " 5.14 " 4.66 "
Dkk1 2.69 " 1.18 3.70 " 2.93 " 4.94 "
Dkk2 2.13 " 1.13 2.98 " 3.12 " 3.69 "
Notch1 0.95 0.60 0.94 0.90 1.16
Sostdc1 1.22 2.21 " 1.63 7.75 6.15 "
Cepba 1.29 1.23 1.48 1.96 " 1.78 "
Pparg 0.78 1.13 1.00 1.33 1.67 "
Msx2 0.45 # 0.52 # 1.90 " 1.40 1.81
Tnfrsf11b 1.62 " 0.88 2.52 " 2.41 " 2.88 "
Tnfsf11 1.05 0.87 2.00 " 3.25 " 2.34 "
Runx2 1.34 0.98 1.91 " 2.20 " 3.70 "
Sp7 1.70 " 1.20 2.95 " 2.85 " 3.73 "
Calca 0.71 0.57 2.94 1.63 
Twist1 1.07 0.48 # 1.08 1.54 2.30 "
Wisp1 2.00 " 1.05 2.70 " 2.62 " 6.13 "
Fold changes represent differential gene expression levels in A/J mice
relative to B6mice. Directional arrows indicate up- or downregulation of
all genes showing a 1.5 or greater fold change (up or down), regardless
of p value. Bold denotes significance at the p< 0.05 alpha level of A/J
gene expression relative to B6 for each time point, regardless of fold
change.
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they are acting in a physiological or pathophysiological state.(53)
However, despite the incongruity between studies, the increase
in Sost expression in both A/J and B6 mice throughout growth is
consistent with the increase in serum sclerostin observed across
growth for human boys and girls,(54) although the association
between SOST expression and serum sclerostin levels is not well
understood.(55) Finding a qualitative correlation between an
increase among Sost and the transition to full ambulation among
mice that have different phenotypic trait sets suggests the
relationship between this keyWnt pathway antagonist and bone
formation is more complex than has been previously shown
among mice that are selectively perturbed. Based on previous
findings, one would expect that as total diaphyseal area (ie, bone
formation) increases by 0.5mm2, Sost expression would
decrease to allow b-catenin to accumulate in the cytoplasm
and translocate to the nucleus to induce Tcf/Lef transcription
factors to drive mesenchymal stem cells toward the osteoblastic
lineage. Therefore, it remains unclear as to what role Sostmay be
playing during the shift to full ambulation. Further investigation
into this relationship is required.
One limitation of this study is that only the gene expression
differences of cells remaining in the cortical matrix after the
removal of the bonemarrow andmusculotendinous tissue were
examined. Presumably, bone cells present along the periosteal
and endosteal surfaces also play an important mediatory role in
external bone size and mineralization. Future work will need to
independently assay the fibrous periosteum and bone marrow
to determine the role these tissues have in regulating the
distribution and composition of bone in space with regards to
the differing diaphyseal phenotypes present in the current
model. For example, others have shown periostin, an extracel-
lular matrix protein that in bone is localized to the periosteum
and expressed by the osteoblastic lineage, to promote collagen
cross-linking via enhancement of lysyl oxidase activation.(51)
Additionally, assays of the associated bonemarrow could inform
on whether signaling pathways responsible for osteoblastic and
osteoclastic differentiation is differentially induced or inhibited
between strains. Another limitation of this study is that we did
not determine whether Sost is differentially expressed across the
periosteal, intracortical, and endosteal envelopes to stimulate a
localized adaptive bone formation response, which may explain
why periosteal bone formation, but not endosteal infilling, was
impeded in A/J mice.
In conclusion, the current study has confirmed that there are
inherent gene expression profile differences between the
cortical diaphysis of two inbred mouse strains that have
different phenotypic trait sets yet similar whole bone function
by skeletal maturity. Therefore, it would appear that the
genotypic background of these mice contributes to their
phenotypic outcome in a canalized manner, as hypothesized.
A/J mice have a narrow femoral diaphysis that is highly
mineralized, which coincides with their gene expression
profile, suggesting that the Wnt pathway is being inhibited
to some degree throughout growth while the ASARM
bone–renal pathway and the greater mineralization functional
network is being activated. Importantly, though the Wnt
Fig. 5. CanonicalWnt gene expression changes in A/J relative to B6mice throughout growth in (A) key pathway inducers and (B) key pathway inhibitors
via custom array cards. Note the collectively greater expression of inhibitory genes of the pathway relative to those that promote induction.
Fig. 6. Sclerostin protein expression in 6-week-old B6 and A/J femora via Western blot. The upper band at 26 kD may be a result of glycosylation, as
sclerostin is believed to have N-glycosylation sites.(57) The right panel shows the relative difference in sclerostin protein expression based on gray value
band intensity at the 23 kD molecular weight.
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pathway appears to be inhibited in A/J femora, this does not
translate to a meaningful difference in absolute Ct.Ar relative
to B6 femora. In addition to this finding, the dichotomy
between high expression level changes among antagonists to
the Wnt pathway in both strains during a period of greater
physiological loads (ie, adult ambulatory activity) and the
decrease in these same antagonists upon the application of
artificial loads, as reported by others, suggests that the role
these genes play in developing and maintaining bone
homeostasis is more complex than previously thought. To
increase our understanding of the role genetic and environ-
mental backgrounds have in establishing function during
growth, future work should focus on teasing apart the
functional networks responsible for coordinating external
bone size, bone mass, and mineralization so that the traits
together lead to a bone with sufficient stiffness and strength
to be functional under physiological loads. Identifying alleles
that may contribute to the physiological differences observed
within an animal model that mimics the natural variation
among complex trait sets known to contribute to the
mechanical competence of bone in humans is of primary
importance. This requires a more systems-based approach,
rather than a reductionist one, to detect interactions both
between genes and between genes and their environment, all
of which contribute to the development of whole bone
function.(1,15) An integrative approach that takes advantage of
mouse strains developed from natural genetic recombinatory
activities over several generations of random breeding may
allow us to better understand the underlying functional
networks responsible for the establishment of whole bone
functional competence.(56)
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